BioAge Labs, Inc. (BIOA)

7.18 -0.03 (-0.42%) USD  |  NASDAQ  |  Sep 25, 14:52
More

BioAge Labs Cash from Operations (TTM) : -87.60M for June 30, 2026

Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for BIOA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -87.60M
March 31, 2026 -88.31M
December 31, 2025 -81.63M
September 30, 2025 -58.51M
June 30, 2025 -57.40M
March 31, 2025 -53.21M
Date Value
December 31, 2024 -51.52M
September 30, 2024 -54.89M
June 30, 2024 -47.72M
March 31, 2024 -43.03M
December 31, 2023 -37.36M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 28.08B
Pfizer Inc. 13.40B
Oramed Pharmaceuticals, Inc. -5.811M
Liquidia Corp. 167.71M
Neumora Therapeutics, Inc. -180.96M